Peroxisome proliferator-activated receptors as therapeutic targets in inflammation.
Plutzky
Jorge
J
D001161:Arteriosclerosis / Q000188:drug therapy / Q000276:immunology; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D007333:Insulin Resistance / Q000276:immunology*; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects / Q000276:immunology*; D045162:Thiazolidinediones / Q000494:pharmacology* / Q000627:therapeutic use; D014157:Transcription Factors / Q000187:drug effects / Q000276:immunology*
D018160:Receptors, Cytoplasmic and Nuclear; D045162:Thiazolidinediones; D014157:Transcription Factors